glp 1 drugs wikipedia The GLP-1 Agonists and Obesity: How Diabetes are Changing Non-Diabetic Lives — tl;dr pharmacy GLP-1 Agonists: A Comprehensive Overview
Description
Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression
They then calculated an incremental cost effectiveness ratio for semaglutide (costing $700 per month per person) of $443,000 per quality-adjusted life year gained
Clin Endocrinol (2009) 71(4):5006
Offer cannot be combined with insurance.
More patients discontinued semaglutide than placebo (16.6% vs
